GEUVADIS in the Press
Beyond genomics: ethical challenges can impinge on the way you do research
Gabrielle Bertier
July 2012
Life@CRG

"If natural scientists tend to see ELSI as just another administrative burden to stop them from performing their research, social scientists viewed me enviously as if I had access to a very nice set of docile ‘lab scientist' guinea pigs. The model we have been able to build in GEUVADIS, and in other EU projects, provides a stark contrast to that."
Web Content Display
GEUVADIS Consortium Seeks to Standardize Clinical Sequencing Efforts
Tracy Vence
7.03.2011
Read Article Genome Web

Investigators at 17 institutions across Europe and the US have banded together in an effort to establish standards for human genome sequencing practice and analysis. The Genetic European Variation in Disease, or GEUVADIS, consortium is coordinated by Xavier Estivill at the Center for Genomic Regulation in Barcelona, and is funded for a period of 36 months by the European Commission under its Seventh Framework Programme
Setting the standard
David Hutton
03.2011
Read Article Drug Discovery News

BARCELONA, Spain—A consortium of European DNA sequencing centers have established the new Genetic European Variation in Disease (GEUVADIS) initiative, bringing together leading medical genome sequencing laboratories to define technological and ethical standards and to promote multi disciplinary training for the global scientific and medical community
El CNAG participa a Geuvadis, un projecte europeu per a implementar la genòmica de forma responsable
Parc Cientific Barcelona
11.02.2011
Read more (Catalan)

El Centre Nacional d'Anàlisi Genòmica (CNAG), amb seu al Parc Científic Barcelona, és un dels disset laboratoris de seqüenciació europeus i dels Estats Units que participen en el consorci GEUVADIS (GEnetic EUropean VAriation in DISease), finançat per la Comissió Europea sota el 7è Programa Marc.
Estandarización de los análisis y buenas prácticas en la secuenciación de genomas humanos
RDi Press
29.01.2011
Read more (Spanish) Red Inovacion Noticias: RDI press

El proyecto GEUVADIS (GEnetic EUropean VAriation in DISease) reúne los principales laboratorios de secuenciación europeos para definir los estándares éticos y tecnológicos para promover la formación multidisciplinaria para toda la comunidad científica y médica
Deciphering human genome sequences
CRG Press Release
24.01.2011
Read More

TOP EUROPEAN SCIENTISTS ESTABLISH A NEW BASIS TO STANDARDIZE ANALYSIS AND PROMOTE GOOD PRACTICE IN HUMAN GENOME SEQUENCING The GEUVADIS (Genetic European Variation in Disease) project brings together Europe's leading medical genome sequencing laboratories to define technological and ethical standards, and to promote multidisciplinary training for the global scientific and medical community.
Deciphering human genome sequences
Alpha Galileo News Release
24.01.2011
Read More

The GEUVADIS (Genetic European Variation in Disease) project brings together Europe's leading medical genome sequencing laboratories to define technological and ethical standards, and to promote multidisciplinary training for the global scientific and medical community.
European Sequencing Centers Form Genomic Standards Consortium
GenomeWeb Daily News
24.01.2011
Read More

NEW YORK (GenomeWeb News) – A consortium of 17 genome sequencing and research labs will work together to define technological and ethical standards and to promote multidisciplinary training in genomics.
Geuvadis in the web
Geuvadis in Nijmegen

20.09.2008
Read More

Full elucidation of the genetic basis of disease requires complete genomic information of both patients and healthy individuals. Next-generation sequencing (NGS) technology makes it possible to read the complete genomes of many individuals at affordable costs and in a short time frame. (...)
Geuvadis in Kiel
Christian Albrecht University of Kiel
2010
Read More

The GEUVADIS (genetic European variation in disease) Consortium aims at developing standards in quality control and assessment of sequence data, models for data storage, exchange and access, as well as standards for the handling, analysis and interpretation of sequencing data and other functional genomics datasets, standards for the biological and medical interpretation of sequence data and in particular rare variants for monogenic and common disorders, and finally standards for the ethics of phenotype prediction from sequence variation (...)
Applied Genomics
X. Estivill V. Blanc
2008
Read more (Spanish)

gEUVADIS deberá fomentar el desarrollo y la aplicación de Medicina Genómica Personalizada a nivel individual y colectivo. Es decir, se trata de desarrollar tratamientos más eficaces, reducir los efectos secundarios indeseables, mejorar el éxito en el diseño de los ensayos clínicos, y desarrollar nuevos conceptos para la prevención (...)